Luminera Hydryalix Ultra Deep Lidocaine – Seringue Hyaluronic Acid Fillers

Luminera Hydryalix Ultra Deep Lidocaine is an injectable, sterile, apyrogenic gel intended for soft tissue augmentation.

Luminera Hydryalix Ultra Deep is an injectable, sterile, pyrogenic gel intended for soft tissue augmentation. It is composed of cross-linked hyaluronic acid from a non-animal source. The gel is latex-free, viscoelastic, clear, transparent, and bio-degradable. Luminera Hydyralix Ultra Deep is indicated for the correction of deep facial wrinkles and folds such as nasolabial folds and for remodeling facial contours. It is to be injected into the deep dermis, subcutaneous, and/or at the pre-periosteal area. Hydraulic Ultra Deep is also designed for injection into the periorbital area (e.g. eyelids, bags under the eyes, eye wrinkles), glabella or periocular area, lips and perioral region, superficial and mid dermis, and superficial wrinkles.

The pack consists of:

2 x 1.25ml prefilled syringe

Benefits of Luminera Hydralix Ultra Deep:

Skin hydration

Correction of deep facial wrinkles and folds (nasolabial folds)

Facial contouring

Treatment areas: deep dermis, eyelids, bags under the eyes, eye wrinkles, glabella, lips, perioral region, and superficial wrinkles

How long does the result last?

The result will appear after one treatment. The duration depends on the degree of correction required and the individual’s lifestyle, age, and skin type.

Recommended needle 25G or 27G thin wall.

Luminera’s state of the art technology for the production of Hydryalix, our cross linked HA line of products, gives the advantages of both monophasic cross linking and biphasic gel properties.

Monophasic gel, which is homogenously cross linked, generates a smooth, uniform gel, lowers side effects, such as swelling and the Tyndall effect, and uses less BDDE for the cross linking process. Monophasic gel is 100% cross linked.

Biphasic gel has two phases, a highly cross linked phase of HA particles and a non-cross linked HA phase in which the particles are suspended. This non cross linked phase is needed to enable the injection.

In our Hybrid MoBi^TM technology, the gel is monophasic, fully homogenous , smooth and easy to inject. The gel is then cut to different particle sizes, generating a line of differentiated products which are intended for diverse indications. The particle nature of the gel gives the ability to mold the injected material to the desired shape in the tissue and gives the product its firmness. A property not found in the standard monophasic products which are available in the market.